Britain&#39;s fertility regulator on Thursday gave the green light for the country to become the first in the world to legally offer &quot;three-parent baby&quot; fertility treatments.

British MPs had voted in February to allow the creation of in-vitro fertilisation (IVF) babies with DNA from three people, but clinics needed the approval of the Human Fertilisation and Embryology Authority before introducing the treatment.

The technique would allow women who carry disease-causing mutations in their mitochondrial genes to give birth to genetically-related children free of mitochondrial disease.

HFEA chair Sally Cheshire called the decision&nbsp;to let clinics offer mitochondrial gene therapy &quot;historic and important&quot; and &quot;a world first&quot;.

&quot;I&#39;m sure patients who might be in line for this treatment will be really pleased by what we&#39;ve decided today,&quot; she said, but added: &quot;We will proceed with caution.&quot;

An independent panel of experts last month said the practice should be &quot;cautiously adopted&quot; to prevent certain genetic diseases from being passed on to future generations.

Mitochondria are structures in cells which generate vital energy and contain their own set of genes called mDNA which is passed through the mother.

Mitochondrial diseases cause symptoms ranging from poor vision to diabetes and muscle wasting and health officials estimate around 125 babies are born with the mutations in Britain every year.

(AFP)

The process would allow women carrying disease-causing mutations in their genes to give birth to genetically-related children free of disease

Britain's fertility regulator on Thursday gave the green light for the country to become the first in the world to legally offer "three-parent baby" fertility treatments. British MPs had voted in February to allow the creation of in-vitro fertilisation (IVF) babies with DNA from three people, but clinics needed the approval of the Human Fertilisation and Embryology Authority before introducing the treatment. The technique would allow women who carry disease-causing mutations in their mitochondrial genes to give birth to genetically-related children free of mitochondrial disease. HFEA chair Sally Cheshire called the decision to let clinics offer mitochondrial gene therapy "historic and important" and "a world first". "I'm sure patients who might be in line for this treatment will be really pleased by what we've decided today," she said, but added: "We will proceed with caution." An independent panel of experts last month said the practice should be "cautiously adopted" to prevent certain genetic diseases from being passed on to future generations. Mitochondria are structures in cells which generate vital energy and contain their own set of genes called mDNA which is passed through the mother. Mitochondrial diseases cause symptoms ranging from poor vision to diabetes and muscle wasting and health officials estimate around 125 babies are born with the mutations in Britain every year. (AFP)

UK approves 'three-parent' gene therapy

three-parent-gene-therapy

Three Parent Gene Therapy, News on Three Parent Gene Therapy, stories on Three Parent Gene Therapy, articles on Three Parent Gene Therapy, Three Parent Gene Therapy stories at Wion, Three Parent Gene Therapy news, Three Parent Gene Therapy latest news

three parent-gene-therapy

UK approves 'three-parent' gene therapy